Amino Acid Neurotransmitters Assessed by Proton Magnetic Resonance Spectroscopy: Relationship to Treatment Resistance in Major Depressive Disorder
- 1 May 2009
- journal article
- research article
- Published by Elsevier BV in Biological Psychiatry
- Vol. 65 (9), 792-800
- https://doi.org/10.1016/j.biopsych.2008.10.025
Abstract
No abstract availableKeywords
Funding Information
- CFIDS Association of America
- National Institutes of Health (K23-MH-069656, MO1-RR-00071, R01-MH07895)
- Weill Cornell Medical College
This publication has 43 references indexed in Scilit:
- Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzoleMolecular Psychiatry, 2008
- Targeting the glutamatergic system to develop novel, improved therapeutics for mood disordersNature Reviews Drug Discovery, 2008
- Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinicNature Neuroscience, 2007
- Impaired GABA Neuronal Response to Acute Benzodiazepine Administration in Panic DisorderAmerican Journal of Psychiatry, 2004
- Life Stress, Genes, and Depression: Multiple Pathways Lead to Increased Risk and New Opportunities for InterventionScience's STKE, 2004
- How accurate are patients in reporting their antidepressant treatment history?Journal of Affective Disorders, 2003
- Increased Occipital Cortex GABA Concentrations in Depressed Patients After Therapy With Selective Serotonin Reuptake InhibitorsAmerican Journal of Psychiatry, 2002
- CSF GABA in depressed patients and normal controlsPsychological Medicine, 1991
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960
- THE ASSESSMENT OF ANXIETY STATES BY RATINGPsychology and Psychotherapy: Theory, Research and Practice, 1959